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Differences in cytochemical and pathophysiologic abnormalities in experimental meningitis
caused by pneumococcal strains A, B, and C were determined. Strain C produced the most se-
vere abnormalities of cerebrospinal fluid (CSF) concentrations of lactate (P < .01), protein (P
< .02), and glucose (P < .01), CSF white blood cell count (P < .04), cerebral blood flow (P <
.02), and clinical signs (P< .05). Brain edema occurred only with strains A and C, with no associ-
ation with disease severity; intracranial hypertension was also independent of disease severity.
Strain B, not C, achieved the highest bacterial titers in the CSF (P < .005). The widely different
abilities ofstrains ofStreptococcus pneumoniae to induce intracranial abnormalities suggest that
virulence determinants affect not only evasion of defense during colonization and invasion, as
shown in other models, but also determine the course of disease once infection has been estab-
lished. Differences of cell-wall metabolism among pneumococcal strains may playa role in this
latter phase of the development of meningitis.
Bacterial meningitis causes death and neurologic sequelae
in a large proportion of patients affected [1-4] by mechanisms
that are currently not well understood [5]. Pathophysiologic
alterations that may contribute to injury to the central nervous
system include disruption sf the integrity of the blood-brain
barrier [6, 7], altered cerebrospinal fluid (CSF) hydrodynamics
[8], increased intracranial pressure [9-11], the development
of brain edema [9, 10], changes of cerebral metabolism [12,
13], and alterations of cerebral blood flow [12-16].
Pneumococcal meningitis has a higher mortality rate than
that caused by either Neisseria meningitidis or Haemophilus
infiuenzae, the two other important meningeal pathogens [3,
17]. Only a minority of the 84 serotypes of Streptococcuspneu-
moniaefrequently cause invasive disease in humans [18]. This
selectivity may be related to differences in the ability of differ-
ent serotypes to colonize and invade the host, but once infec-
tion is established the overall clinical significance of a strain
is also the result of its ability to induce severe disease. Little
is known about these latter aspects of virulence in pneumo-
coccal meningitis.
In the present study we examined pathophysiologic altera-
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tions of meningitis induced by three pneumococcal strains.
We used a model of meningitis in which the infecting patho-
gen is directly inoculated into the CSF [19] to test the hy-
pothesis that strain-specific microbial factors operative once
the pathogen has reached the subarachnoid space are impor-
tant determinants of disease severity.
Materials and Methods
Characterization of bacterialstrains. Three encapsulated strains
of S. pneumoniae isolated from patients with meningitis were used
in the study. The capsular types of the three strains were 3, 1, and
9 for strains A, B, and C, respectively (strains Band C were a gift
from 0. Zak, Ciba-Geigy, Basel, Switzerland). Strain A produced
very large, mucoid colonies on blood-agar plates, while the two other
strains grew to much smaller, smooth colonies. Capsular expres-
sion was stable in vitro and after passage through rabbits. In vitro
doubling times in Todd-Hewitt broth were 27 min for strain A and
33 min for strains Band C. Spontaneous release ofteichoicated cell-
wall material in vitro was estimated by prelabeling the teichoic acid
and lipoteichoic acid of the pneumococcal cell surfaces with 1 11- Cit
ml [3H]choline (Amersham Radiochemicals, Arlington Heights, IL)
for 6 h, growing the strains in unlabeled medium for 2 h, and then
measuring [3H]choline in cell wall precipitated in boiling SDS [20].
During logarithmic growth in a semisynthetic medium, C + Y[20],
release of [3H]choline was on the order of only 4 %-5 % per gener-
ation for strains Band C, while strain A lost 12% per generation.
In the stationary phase, spontaneous release of cell wall was
significantly less for strain B (51%over 12 h) compared with C (78%)
or A (94%). All strains were sensitive to penicillin (MIC ~ 0.03
mg/l). Strains A and B exhibited a classic lysis-sensitive response
to penicillin (>60%reduction in turbidity at 4 h), while the response
of strain C to penicillin paralleled that of a lysis-defective strain lyt
4-4 «20% reduction of turbidity at 4 h) [20].
To produce the inoculum for the animal studies, the organisms
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were grown on blood-agar plates, resuspended in 0.9% NaCI, and
stored at -70°C. To infect the rabbits, the thawed inoculum was grown
in Todd-Hewitt broth for 6 h, washed, and suspended in 0.9% NaCI.
Preparation ofcell-wall extracts. Pneumococcal cell-surface com-
ponents were prepared according to methods described previously
[21]. Intact cell wall was purified as described for preparation A,
peptidoglycan free of teichoic acid was prepared as in preparation
C, and cell-wall fragments generated during penicillin-induced ly-
sis (amidase products) were made as in preparation F. Each compo-
nent was compared for activity on a weight basis when injected
intracisternally.
Model of experimentalmeningitis. The model of experimental
meningitis in rabbits, originally described by Dacey and Sande [19],
was modified to allow the study of pathophysiologic parameters [9,
22]. New Zealand white rabbits weighing 2-3 kg were anesthetized
intravenously with 30 mg of pentobarbitol/kg (Nembutal; Abbott,
Cham, Switzerland) and a helmet formed with dental acrylic was
attached to the skull by four screws. The animals were then returned
to their cages for 3 days. On the day of the experiment, the anesthe-
tized animals were placed in a stereotactic frame (courtesy of O.
Zak) designed to puncture the cisterna magna with a 3.5-inch (8.9-
cm)/25-gauge spinal needle (Becton Dickinson, St. Augustine,
Spain), After puncture of the cisterna, 0.5 ml of CSF was removed.
To induce meningitis caused by live organisms, an inoculum of 0.5
ml was injected into the cisterna magna. Four animals and two of
the three experimental strains were studied on the same day, and
animals were randomly assigned to one of the infecting strains (3)
or saline control (1). The inoculum was 0.7-1.5 x 107 cfu for strain
A, 3.5 x 104-2 x.lOS cfu for strain B, and 2 x 104-2.5 X 105
cfu for strain C. To induce sterile meningitis caused by cell walls,
cell-wall preparations suspended in 0.5 ml were injected at 0 h and 4 h.
After induction of meningitis, the animals were allowed to wake
up and returned to their cage. Animals were anesthetized again 24 h
after the first injection when infected with live organisms and 8 h
after the first injection when meningitis was induced by cell walls.
The cisterna magna was punctured and 0.5 ml of CSF was removed.
An equal amount of O. 9 % NaCI was replaced through the spinal nee-
dle. The spinal needle was removed, and an intraarterial line was
placed in one femoral artery in the infected groups.
Experimental parameters. Bacterial titers, white blood cell
(WBC) counts, and CSF concentrations of lactate, glucose, and pro-
tein were determined by routine methods as described previously
[9, 22]. Intracranial pressure was recorded from the spinal needle
placed in the cisterna magna, using a pressure transducer and poly-
graph as described previously [9, 22]. Pressures were identical when
measured before removal or after replacement of CSF by the same
volume of saline. Brain water content (brain edema) was determined
as wet-to-dry-weight ratio of one hemisphere and two 100-mg sam-
ples of gray matter of the opposite hemisphere and was expressed
as grams of water per 100 grams of dry weight [9, 22].
Cerebral blood flow was determined by using a modified [l4C]io-
doantipyrine method [23-25]. Before the blood-flow measurement,
blood pressure was recorded from the intraarterial line using a pres-
sure transducer (Gould Statham model P32ID; Gould, Oxnard, CA)
and a multichannel polygraph (Gilson Medical Electronics, Mid-
dleton, WI). Arterial blood gases were measured at this time on
an automatic blood gas analyzer (AVL 940; AVL, Graz, Austria).
To determine cerebral blood flow, [l4C]iodoantipyrine (20 #LCi;
Amersham International, Amersham, UK) in 0.5 ml of 0.9% NaCI
was injected into a peripheral ear vein. During the next 50 s, 15
timed blood samples were collected from the free-flowing arterial
line into preweighed glass vials. Immediately thereafter, animals were
decapitated and the brain was removed from the skull. One sample
of cortical gray matter from the right parietal lobe, one from the
right occipital lobe, and one of the periventricular white matter were
collected. All samples weighed ""100 mg. The samples were solu-
bilized in 1 ml (50%/50%) of isopropyl alcohol/soluene 350 (Pack-
ardInstrwnents B.V., Groningen, Netherlands) [25]; 10 ml ofhionic
fluor (Packard Instruments B.V.) was then added, and 14C counts
were determined in a liquid scintillation counter (Packard Tri-Carb
Liquid Scintillation Spectrometer; Packard Instruments, Downers
Grove, IL). Cerebral blood flow was calculated according to the equa-
tion developed by Kety [26]. Since there was no systematic differ-
ence between the two cortical samples, the mean of these values is
given.
Statistical analysis. Data are presented as mean ± SD. For each
end point, with the exception of WBC counts, equality between the
experimental groups was tested by analysis of variance. If significant
differences between experimental groups (P < .05) were found, they
were further evaluated by Student's t test corrected for multiple com-
parisons by the Bonferroni method. In the case of CSF WBC counts,
nonparametric tests were used (Kruskal-Wallis followed by Mann-
Whitney rank sum tests) due to nonnormality of the data.
Results
Pathophysiologyofmeningitis caused by livepneumococci.
At 24 h after infection, animals infected with strain C were
severely ill (lateral recumbent position in 6/12 animals,
hypothermia [<39°C in an animal with infected CSF] in 6/12
animals). In contrast, none of 9 animals infected with strain
A and 1 of 11 animals infected with strain B showed signs
of severe illness (P < .05 for C vs. other groups combined).
All infected animals had positive CSF cultures, but there
were significant differences in bacterial titers in the CSF, with
strain B showing the highest titers, strain C being intermedi-
ate, and strain A being the lowest (P < .005; table 1). CSF
lactate concentrations were also significantly different in the
three infected groups (table 1). All infected animals had
elevated CSF lactate concentrations compared with controls
(P < .01), but lactate concentrations progressively increased
from strain A to B to C (5.5 ± 2.3 to 10.8 ± 2.4 to 17.0 ±
4.0 mmol/l; P < .01). CSF protein concentrations showed
a pattern similar to that of lactate, although with less-pro-
nounced differences among the three strains (table 1). CSF
glucose levels were comparable with those of controls in the
animals infected with strains A and B, but were significantly
reduced in animals infected with strain C (P < .01). CSF WBC
counts were highest in animals infected with strain C (P <
.04), while there was no significant difference between the
two other infected groups (table 1). Thus, CSF cytochemical
changes showed marked differences among the three ex-
perimental groups, with animals infected with C, the strain
that caused the most severe clinical signs, also showing the
most abnormal CSF cytochemical changes. Of note, the differ-
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ences among the three strains were independent of their respec-
tive CSF bacterial titers.
Gray matter brain edema developed in animals infected with
strain A and to a similar degree in animals infected with strain
C (P < .01) but not in animals infected with B (table 2).
Hemispheric water contents showed similar differences among
groups, but without achieving significance due to the rela-
tively low numbers of animals and multiple comparisons (ta-
ble 2). Cerebral blood flow also showed significant differences
among the three experimental groups. Cortical blood flow was
highest with strain A, lower with B, and lowest with C (P
< .02; table 2). Of note, comparison with uninfected con-
trols showed that cortical blood flow was increased with strain
A and B (table 2). Flow in the subcortical white matter showed
a decrease with infection that gradually progressed from strain
A (mildest disease) to strain C (most severe disease; P< .04;
table 2).
Comparison of intracranial pressure, mean arterial blood
pressure, blood pH, and arterial Pco, revealed the least pro-
nounced differences among the three experimental groups
(table 3). Compared with uninfected controls, intracranial
pressure was elevated in infected animals (P < .001)but with-
out significant differences among the three experimental
groups (table 3). Mean arterial blood pressure was higher with
strain B, while the other two groups had pressures similar
to uninfected controls. All infected animals hyperventilated
compared with uninfected controls (P < .001; table 3). Mean
arterial pH was slightly elevated in infected animals (P < .001
for strain B vs. uninfected controls; table 3).
Meningitis induced by cell-wallfractions. Pneumococcal
cell wall induces CSF inflammation [21, 27], and it has been
proposed that the amount and composition of cell-wall frac-
tions released from infecting strains could modulate some
aspects of meningitis [20]. We therefore examined the abili-
Table 1. Cerebrospinal fluid content determinations in rabbits with .experimental pneumococcal meningitis.
Infecting strain
Control A B C
(n = 13) (n = 9) (n = 11) (n = 12)
Bacterial titer, logm cfu/ml Sterile 5.20 ± 0.76* 8.10 ± 0.36* 6.91 ± 0.89*
WBC count per mm'' 23 ± 31t 1573 ± 1051 1293 ± 1290:1: 5570 ± 7470+
Lactate concentration, mmol/l 1.9 ± 0.2§ 5.5 ± 2.3§ 10.8 ± 2.4§ 17.0 ± 4.0§
Protein concentration, gIl 0.25 ± 0.14 0.65 ± 0.72 1.22 ± 0.73 3.06 ± 2.1511
Glucose concentration, mmol/l 4.12 ± 0.42** 3.90 ± 0.57 3.48 ± 1.35 2.75 ± 1.22**
NOTE. WBC = white blood cells.
* p < .005 among three strains; t p < .01 vs. infected (nonparametric tests); *P < .04 (nonparametric tests); § P < .01 (comparing each group to each of the others);
II P < .01 vs, other groups; ** P < .01.
Table 2. Brain edema and cerebral blood flow in rabbits with experimental pneumococcal meningitis.
Infecting strain
Control A B C
(n = 13) (n = 9) (n = 11) (n = 12)
Brain edema, g of H20/l00 g of dry weight
Hemisphere 373.7 ± 7.6 383.1 ± 7.5 375.9 ± 15.8 381.2 ± 10.3
Gray matter 437.9 ± 10.7 457.7 ± 8.9* 445.2 ± 12.3t 456.2 ± 20.4*
Blood flow, mI/lOO g/min
Gray matter 52.8 ± 5.9 68.9 ± 6.2+ 60.8 ± 8.5§ 49.4 ± 11.6§
White matter 27.6 ± 7.311 25.9 ± 2.4§ 21.7 ± 4.011 19.0 ± 4.0§
* P < .01 vs. control; t not significant vs. control; *P < .001 vs. control and vs. strain C; § P < .02; II P < .04.
Table 3. Physiologic factors in rabbits with experimental pneumococcal meningitis.
Infecting strain
Intracranial pressure, mm Hg
Mean arterial blood pressure, mm Hg
Arterial pH
Arterial PC02, kPa
* P < .001 vs, other groups; t P < .01; *P < .001.
Control
(n = 13)
0.5 ± 1.0*
84.1±4.3
7.41 ± 0.04:1:
5.31 ± 1.07*
A
(n = 9)
7.7 ± 1.9
82.9 ± 8.0
7.51 ± 0.04
2.50 ± 0.51
B
(n = 11)
5.3 ± 3.4
91.3 ± 9.9t
7.56 ± 0.11:1:
1.84 ± 0.48
C
(n = 12)
5.2 ± 3.5
79.3 ± 11.0t
7.50 ± 0.12
1.82 ± 0.62
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ties of intact and fractionated pneumococcal cell walls to in-
duce pathophysiologic alterations beyond the cytochemical
abnormalities in the CSF that have previously been described
[21,27]. Whole cell-wall (20 p.g X 2) induced abnormalities
in all these parameters similar to those seen in true menin-
geal infection, including increased intracranial pressure (5.0
± 3.8 mm Hg) and brain edema (hemisphere: 385.8 ± 11.9
g of H20/100 g of dry weight). The products of penicillin-
induced autolysis (amidase products, 5 p.g), which consist of
teichoicated and nonteichoicated soluble wall fragments [21],
also induced significant changes in all examined parameters.
The glycan backbone (15 p.g X 2) stripped of teichoic acid,
on the other hand, provoked a significantly reduced CSF
pleocytosis (P < .02), milder increases in cytochemical
changes and intracisternal pressure (1.4 ± 1.9 mm Hg), and
no brain edema (hemisphere, 376.3 ± 6.8 g of H20/100 g of
dry weight). Thus, pneumococcal cell-wall fractions can, de-
pending on their chemical composition, induce pathophysio-
logic alterations similar to those induced by live organisms.
Discussion
Traditionally, the age of the patient, the species of the infect-
ing organism, and the time to institution of effective anti-
microbial therapy are among the most important variables that
determine the clinical presentation and outcome of meningi-
tis. The present expeiimental study suggests that strain-specific
characteristics of pneumococci operative during multiplica-
tion of the pathogen in the host may have more pronounced
effects on the presentation of the disease than has been recog-
nized. We found that infection with three different pneumo-
coccal isolates resulted in pronounced differences in the
pathophysiologic profiles 24 h after intracisternal inoculation.
Previous clinical and experimental studies of pneumococ-
cal meningitis have shown that high CSF lactate and protein
concentrations and low CSF glucose concentrations are as-
sociated with severe disease [28-32]. By these criteria the
severity of disease was markedly different in the three ex-
perimental groups in this study. Animals infected with strain
C showed by far the most severe CSF cytochemical changes,
which were associated with clinical signs of severe illness in
these animals. Clinically, the two other groups could not be
distinguished, but CSF lactate concentrations were greater
in animals infected with strain B than in animals infected with
strain A. These differences were paralleled by survival times
after infection with the three strains. Animals infected with
strain C had the shortest survival, while it was intermediate
with strain B and longest with strain A (data not shown).
Even though brain edema has been consistently documented
in several previous studies of experimental meningitis, includ-
ing studies with pneumococci [9, 22], H. influenzae [10] and
E. coli [33], it failed to develop in animals infected with strain
B, the strain that caused intermediate disease. Furthermore,
there was no appreciable difference in the degree of edema
between the two other groups, despite their marked differ-
ence in disease severity. This suggests that brain edema, as
measured in this experimental model, may not always be a
direct correlate of the severity of meningitis. The results with
pneumococcal cell-wall fragments in the present study sug-
gest that the chemical composition of the fragments, speci-
fically the degree of teichoication, may be important for the
induction of brain edema during pneumococcal meningitis.
Teichoication appears also to be an important determinant
of the inflammatory potential of pneumococcal cell walls [34].
Conceivably, the inability of strain B to induce brain edema
could be related to its intrinsically low level of spontaneous
cell-wall release. Direct support for this hypothesis awaits the
ability to create isogenic mutant strains that differ in their
regulation of cell-wallmetabolism. That liberation of bacterial
products can be important for the development of brain edema
during meningitis was shown in experimental E. coli meningi-
tis, where the amount of endotoxin released from the infecting
pathogen strongly influenced the degree of brain edema [33].
Measurements of cerebral blood flow also provided some
results that were unexpected on the basis of previous studies
[13-16]. critical blood flow was markedly increased in the
least-sick animals infected with strain A. Although blood flow
decreased as the disease became more severe, even animals
with the most severe disease (strain C) had, on average, cor-
tical blood flows that were not markedly lower than in unin-
fected controls. Previous studies have suggested that cerebral
blood flow is generally reduced in bacterial meningitis [13-15].
No attempt has been made in most of these studies to corre-
late blood flow changes to the severity of the disease nor to
specific characteristics of the infecting pathogen. Our results
suggest that mild disease can be associated with increased
rather than decreased cortical blood flow and that only se-
vere illness may be associated with reduction of cerebral blood
flow to critical levels.
Some pathophysiologic alterations measured in this study
lacked the major differences between experimental groups
found for CSF cytochemistry and cerebral blood flow. At least
for intracranial pressure, the lack of differences may not be
too surprising. Several factors, such as altered cerebral blood
flow [16], altered CSF hydrodynamics [8], and brain edema
[9] can affect intracranial pressure. This makes intracranial
hypertension a relatively nonspecific alteration because its
different determinants do not necessarily change in parallel,
thus potentially neutralizing each other in their effect on in-
tracranial pressure.
Our study does not establish an explanation for the differ-
ences in disease caused by the three pneumococcal strains.
In contrast to a study of cerebral blood flow in experimental
meningitis with a single strain of H. injluenzae, in which a
strong correlation was found between CSF bacterial titers and
changes in blood flow [35], the absolute bacterial titers in th~
CSF obviously did not explain the differences in disease in
the present study. Chemical differences among the capsules
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of the strains are also not a likely explanation for the clinical
diversity of the disease. The role of the capsule in the viru-
lence of pneumococci is mainly to protect the microorgan-
ism from phagocytosis in the absence of capsule-specific
antibodies [36, 37]. Previous studies using the same model
of meningitis have shown that phagocytosis of pneumococci
in the CSF appears to be minimal during the first 24 h of ex-
perimental meningitis [38]. Also, the capsule has been found
to almost completely lack inflammatory potential in this model
of meningitis [27]. These findings make a major role of the
capsule for pathophysiologic variables unlikely.
Our results with the cell-wall fractions and previous studies
with similar preparations indicate that the bacterial cell wall
could play a role in mediating disease in pneumococcal in-
fections [20, 39,40]. Similar to endotoxin in the case of gram-
negative organisms, cell-wall fragments can induce the release
of interleukin-l, and to a lesser extent cachectin, from mono-
nuclear cells [41]. In bacterial meningitis, these cytokines are
essential in mediating the inflammatory changes and other
pathophysiologic features of the disease, such as the disrup-
tion of the blood-brain barrier and the development of brain
edema [42-46]. Future studies must examine whether the
amount or pattern of cytokine release during meningitis affects
the pathophysiologic spectrum of the disease and how char-
acteristics of the infecting microorganism may be related to
cytokine release. It is interesting in this context that the most
severe abnormalities in the present study were associated with
strain C, which abruptly released cell wall in stationary phase.
Strain A on the other hand, which readily released cell wall
during all growth phases in vitro, caused only mild disease.
The relatively low bacterial load of this strain in the CSF could
explain the apparent discrepancy between cell-wall turnover
and severity of the disease. Differences in CSF bacterial titers
achieved by the different strains could result from different
susceptibilities of the strains to growth inhibition by high tem-
perature. We have previously shown that growth of strain A
is markedly reduced in febrile rabbits [47]. Clearly, more work
is needed to characterize differences in cell-wall metabolism
among the three strains and to explore the relevance of these
differences for the clinical expression of the disease caused
by these strains.
Obviously, many bacterial components (e.g., enzymes [48],
surface proteins [49]) could be important in modulating the
disease caused by a specific strain. In light of the likely com-
plexity of the interaction between microorganisms and host,
the role of any putative virulence factor should ideally be de-
fined by studying isogenic strains differing only in this variable.
Our observation of the pronounced, strain-specific differences
in the pathophysiologic spectrum of experimental pneumococ-
cal meningitis should prompt further efforts to understand
these phenomena on a molecular level.
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